ABOUT

Syqe’s mission to accelerate delivery of the most effective medicine, to the largest number of patients, through an advanced administration platform adhering to pharmaceutical standards.

Our robust inhalation system is designed to deliver a wide range of drugs – from raw phyto-substances to pharmaceutical substances, targeting cannabis as 1st candidate and becoming the standard of care for medical cannabis.
The Syqe inhaler is the world’s first regulatory approved medical device preloaded with a controlled substance. Based in Tel Aviv, Syqe is committed to best-in-class in performance, reliability, and safety. Syqe continues to innovate and scale with the goal of redefining the standard of care and delivering the most effective treatment to patients.